Showing 1801-1810 of 3695 results for "".
The Importance of Employee Engagement
https://practicaldermatology.com/topics/general-topics/the-importance-of-employee-engagement/20639/The most valuable asset to your medical practice is not what you think.Know Your Lesions: The Many Variations of Seborrheic Keratosis
https://practicaldermatology.com/topics/skin-cancer-photoprotection/know-your-lesions-the-many-variations-of-seborrheic-keratosis/20679/SKs are benign lesions that may be removed for medical or aesthetic reasons. It's essential to distinguish SKs from malignant lesions.Interoperability Redux
https://practicaldermatology.com/topics/practice-management/interoperability-redux/20455/Is the new push for interoperability déjà vu all over again?Marathon Dermatology
https://practicaldermatology.com/topics/general-topics/marathon-dermatology/20997/As the popularity of running continues to grow, dermatologists need rapid ready responses to address acute presenting problems, as well as counseling measures to help prevent recurrence.Integrating Excimer Laser Therapy for Psoriasis and Vitiligo
https://practicaldermatology.com/topics/psoriasis/integrating-excimer-laser-therapy-for-psoriasis-and-vitiligo/22959/New patient and practice support programs may expand interest in laser therapy for common medical conditions.Physician Programs: Opening new Patient Gateways
https://practicaldermatology.com/topics/practice-management/physician-programs-opening-new-patient-gateways/22914/Physician programs support dermatologists' practice building and provide a gateway for additional services.Considering Liver Health in Psoriasis: New Assessment Options
https://practicaldermatology.com/topics/psoriasis/considering-liver-health-in-psoriasis-new-assessment-options/23429/A rapid, non-invasive liver exam addresses growing need for early identification and monitoring of liver disease among patients with psoriasis.Biosimilar Medicines in Dermatology: Key Aspects
https://practicaldermatology.com/topics/psoriasis/biosimilar-medicines-in-dermatology-key-aspects/22929/After the recent enactment of a specific approval pathway for biosimilars and publication of the first draft guidelines on biosimilar product development by the FDA, biosimilars are expected to be available in the US soon.How Viable is Pay-for-Performance in Dermatology?
https://practicaldermatology.com/topics/general-topics/PD0509_03-php/22825/Though Pay-for-Performance has affected primary care medicine for years, it has only recently expanded into specialized medicine. Experts discuss its eventual impact on dermatology.Recent Developments
https://practicaldermatology.com/columns/recent-developments/recent-developments/20533/